XILIO THERAPEUTICS INC. - COMMON STOCK
0.9750
26-十二月-24 16:45:00
15 分钟延时
股票
-0.1750
-15.22%
今日范围
0.9600 - 1.1500
ISIN
N/A
来源
NASDAQ
-
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
16 6月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 5月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
17 5月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
12 5月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 4月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
01 3月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference
28 2月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
03 2月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
20 1月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
06 1月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
02 12月 2021 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Closing of Initial Public Offering
26 10月 2021 16:05:00 条件 Nasdaq GlobeNewswire